Prostate Cancer Early Detection

Prostate Cancer Early Detection

These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. w w w w w ¥ Þ † These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.

Early Detection of Prostate Cancer

Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer-related death for men in the United States. The introduction and routine use of serum prostate-specific antigen (PSA) testing in men at risk for the disease has led to significant changes in prostate cancer incidence, presentation and treatment. It is believed that these changes will eventually translat...

Prostate Cancer Early Detection, Version 1.2014

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate c...

NCCN Prostate Cancer Early Detection Panel Members

Early detection and treatment of prostate cancer.

INSTRUCTIONS The following case study, “Early Detection and Treatment of Prostate Cancer” is accompanied by a continuing medical education (CME) evaluation that consists of 5 multiple-choice questions. After reading the case study, carefully consider each of the questions in the CME evaluation on page 67. Then, circle your selected answer to each question on the CME evaluation form on page 68. ...